A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo Authors
Received: 18 June 2007 Revised: 31 July 2007 Accepted: 15 August 2007 DOI:
Cite this article as: Malik, T., Sauder, C., Wolbert, C. et al. Journal of NeuroVirology (2007) 13: 513. doi:10.1080/13550280701658382 Abstract
Mumps virus is highly neurotropic, with evidence of infection of the central nervous system in more than half of clinical cases. In the prevaccine era, mumps was a major cause of viral meningitis in most developed countries. Despite efforts to attenuate the virus, some mumps vaccines have retained virulence properties and have caused aseptic meningitis in vaccinees, resulting in public resistance to vaccination in some countries. Ensuring the safety of mumps vaccines is an important public health objective, as the need for robust immunization programs has been made clear by the recent resurgence of mumps outbreaks worldwide, including the United States, which in 2006 experienced its largest mumps outbreak in 20 years. To better understand the molecular basis of mumps virus attenuation, the authors developed two infectious full-length cDNA clones for a highly neurovirulent strain of mumps virus. The clones differed at only one site, possessing either an A or G at nucleotide position 271 in the F gene, to represent the heterogeneity identified in the original virulent clinical isolate. In comparison to the clinical isolate, virus rescued from the A-variant cDNA clone grew to higher cumulative titers
in vitro but exhibited similar cytopathic effects in vitro and virulence in vivo. In contrast, virus rescued from the G-variant cDNA clone, in comparison to the clinical isolate and the A-variant, was more fusogenic in vitro but replicated to lower cumulative titers and was less neurovirulent in vivo. These data suggest that nucleotide position 271 in the F gene plays a significant role in virus pathogenesis. This infectious clone system will serve as a key tool for further examination of the molecular basis for mumps virus neurovirulence and neuroattenuation. Keywords infectious clone system neurotoxicity paramyxovirus reverse genetics
Tahir Malik and Christian Sauder contributed equally to this work.
Salary support for C. Sauder and C. Wolbert was provided by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration.
Afzal MA, Marsden S, Hull RM, Pipkin PA, Bently ML, Minor PD (1999). Evaluation of the neurovirulence test for mumps vaccines.
Amexis G, Rubin S, Chatterjee N, Carbone K, Chumakov K (2003). Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains.
J Med Virol
Arruda WO, Kondageski C (2001). Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Parana, Brazil, 1998.
Rev Inst Med Trop Sao Paulo
Bang HO, Bang J (1943). Involvement of the central nervous system in mumps.
Acta Med Scand
Brown EG, Furesz J, Dimock K, Yarosh W, Contreras G (1991). Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients.
Buchholz UJ, Finke S, Conzelmann KK (1999). Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.
Carbone KM, Rubin. (2007) Mumps virus. In:
Fields virology. Knipe DM, Howley PM (eds). Philadelphia: Wolters Kluwer, Lippinocott Williams & Wilkins, pp 1527–1542.
Castilla J, Garcia CM, Barricarte A, Irisarri F, Nunez-Cordoba JM, Barricarte A (2007). Mumps outbreak in Navarre region, Spain, 2006–2007.
Centers for Disease Control and Prevention (2006a). Brief report: update: mumps activity—United States, January 1–October 7, 2006.
MMWR Morb Mortal Wkly Rep
Centers for Disease Control and Prevention (CDC) (2006b). Mumps epidemic—United Kingdom, 2004–2005.
MMWR Morb Mortal Wkly Rep
Clarke DK, Sidhu MS, Johnson JE, Udem SA (2000). Rescue of mumps virus from cDNA.
Elango N, Varsanyi TM, Kovamees J, Norrby E (1988). Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus.
J Gen Virol
Kojouharova M, Kurchatova A, Marinova L, Georgieva T (2007). Mumps outbreak in Bulgaria, 2007: a preliminary report.
Lemon K, Rima BK, McQuaid S, Allen IV, Duprex WP (2007). The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.
Love A, Rydbeck R, Ljungdahl A, Kristensson K, Norrby E (1986). Selection of mutants of mumps virus with altered structure and pathogenicity in vivo.
Malik T, Wolbert C, Mauldin J, Sauder C, Carbone K, Rubin S (2007). Functional consequences of attenuating mutations in the hemagglutinin-neuraminidase, fusion and polymerase proteins of a wild type mumps virus strain.
J Gen Virol
Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, Nash J, MacFarlane L, Tettmar R (1993). Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children.
Paterson RG, Lamb RA (1990). RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts.
Rubin SA, Afzal MA, Powell CL, Bentley ML, Auda GR, Taffs RE, Carbone KM (2005). The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
J Infect Dis
Rubin SA, Pletnikov M, Taffs R, Snoy PJ, Kobasa D, Brown EG, Wright KE, Carbone KM (2000). Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans.
Rubin SA, Snoy P, Wright KE, Brown EG, Reeve P, Beeler JA, Carbone KM (1999). The mumps virus neurovirulence safety test in rhesus monkeys: a comparison of mumps virus strains.
J Infect Dis
Schmid D, Pichler AM, Wallenko H, Holzmann H, Allerberger F (2006). Mumps outbreak affecting adolescents and young adults in Austria, 2006.
Spanaki A, Hajiioannou J, Varkarakis G, Antonakis T, Kyrmizakis DE (2007). Mumps epidemic among young British citizens on the island of Crete.
Sugiura A, Yamada A (1991). Aseptic meningitis as a complication of mumps vaccination.
Pediatr Infect Dis J
Szomor K, Molnar Z, Huszti G, Ozsvarne CE (2007). Local mumps outbreak in Hungary, 2007.
Tesovic G, Lesnikar V (2006). Aseptic meningitis after vaccination with L-Zagreb mumps strain—virologically confirmed cases.
Weibel RE, Buynak EB, McLean AA, Hilleman MR (1979). Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines.
Proc Soc Exp Biol Med
PubMed Copyright information
© Journal of NeuroVirology, Inc. 2007